PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016. - Test2 - elhamkhani - TriplyDB

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.

http://www.wikidata.org/entity/Q37549374

about

Assessing Screening Guidelines for Cardiovascular Disease Risk Factors using Routinely Collected Data.PCSK9 and infection: A potentially useful or dangerous association?MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis.Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.Management of Statin Intolerance in 2018: Still More Questions Than Answers.Hypercholesterolaemia - practical information for non-specialists.

P2860

Q38659162-215F42D1-BD7F-4DEE-B768-477BB073AB3C Q38748867-2DD2D884-1AF1-4F46-9DE1-03C3B6B35A03 Q39324079-FC4A767E-64AF-47B7-AAD2-58A5D7E3A509 Q39456483-A133FB91-2B57-4E0A-ABEA-CBAE65120EBB Q41549715-35BB2F7E-90C2-4DE7-84A1-23159FF42BBD Q48274059-D6101537-68ED-4A7C-8255-8CBB86BAB9B6 Q49592460-938BE209-C60D-48F9-A6B8-671A4E78577F

P2860

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.

http://www.wikidata.org/entity/Q37549374

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PoLA/CFPiP/PCS Guidelines for ...... as for Family Physicians 2016.

@en

PoLA/CFPiP/PCS Guidelines for ...... as for Family Physicians 2016.

@nl

type

label

PoLA/CFPiP/PCS Guidelines for ...... as for Family Physicians 2016.

@en

PoLA/CFPiP/PCS Guidelines for ...... as for Family Physicians 2016.

@nl

prefLabel

PoLA/CFPiP/PCS Guidelines for ...... as for Family Physicians 2016.

@en

PoLA/CFPiP/PCS Guidelines for ...... as for Family Physicians 2016.

@nl

P1433

Q37549374-A051CAB7-FE05-4A67-9A35-088FC9B5210B

P1476

Q37549374-BA8A6299-1B58-49D7-9B54-0C4DDED337E7

P2093

Q37549374-0E9663F3-C95D-4BC6-B1F5-CD9673A32305

Q37549374-16DE6676-A417-451D-BE6A-17BD7B1BEEE8

Q37549374-7B456025-D593-4506-B872-473F888A429A

Q37549374-82FEF667-1F38-4C1A-AA51-B09301F4E203

Q37549374-A632A7AC-B7EF-455E-9C42-5B1935242DCE

Q37549374-AF4D6DA2-7292-4AAB-BF28-0A052153F535

Q37549374-BCACCBD2-68E8-4C09-BD32-0B28CB256F61

P2860

Q37549374-032C229B-8C4A-41BC-955F-3F59B04AA867

Q37549374-07BAC260-E660-49DC-8A5B-B3993488BCE7

Q37549374-09B1BEC8-07EE-4818-8789-1B0907B8E91F

Q37549374-0BA1E25C-3C1E-4CC0-B00D-1017135D49C3

Q37549374-0BDCDCCC-B0C0-4D84-A06C-977D5A0F7E04

Q37549374-0C194797-1099-4B8C-9CBE-274F56C77A15

Q37549374-0DC0F345-3B9A-49C7-A63C-E3899B432226

Q37549374-1072AE66-2F42-416C-9C98-051C4C580345

Q37549374-108C464B-6FC4-482F-9215-B25369112A2E

Q37549374-13D8CB56-7BF4-4151-8FCD-CD76F7B3D21C

P304

Q37549374-7A45A9AD-49E9-4A07-B1F1-0342A11C6799

P31

Q37549374-A9C915C5-476C-4D5B-BF2C-6852FA3278D4

P356

Q37549374-30A02F0C-FDAA-4B70-B982-35660FE82207

P433

Q37549374-E98CE0FF-4BC3-4408-8E65-5D99BBC8BB6E

P478

Q37549374-EA8E6E71-E131-4770-890F-0A975224B308

P50

Q37549374-188D360B-BDFD-412C-89B9-01E8DD7D6919

Q37549374-206C177E-A35A-4D31-81E9-92BC3B380106

Q37549374-2435C6CA-D81B-4658-840D-0FDFBD687EE9

Q37549374-2D1F2FE2-EC69-4C95-8A8B-F993B3D1CEA4

Q37549374-5563C6E7-7B8B-4910-B604-C809880079D9

Q37549374-B662AB61-95C3-4E33-8676-4EAEDA84480C

P577

Q37549374-1E7CDB0E-15FB-4A03-98F9-08D314B60FE1

P698

Q37549374-A95CF846-17E6-45B8-AD18-914292E606CF

P921

Q37549374-6408ED9F-1BB1-44B6-93D3-A72B660C06A8

P932

Q37549374-98574C0D-FC40-43F7-B592-A55490F431D4

P356

AOMS.2017.64712

P1433

Archives of Medical Science

P1476

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016

@en

P2093

Agnieszka Jankowska-Zduńczyk

http://www.w3.org/2001/XMLSchema#string

Barbara Cybulska

http://www.w3.org/2001/XMLSchema#string

Jacek Jóźwiak

http://www.w3.org/2001/XMLSchema#string

Marlena Broncel

http://www.w3.org/2001/XMLSchema#string

Piotr Hoffman

http://www.w3.org/2001/XMLSchema#string

Piotr Jankowski

http://www.w3.org/2001/XMLSchema#string

Tomasz Guzik

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for the primary prevention of cardiovascular disease

Lipid-lowering for peripheral arterial disease of the lower limb

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland

Lipids, blood pressure and kidney update 2015

Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials

Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

Statins, cognition, and dementia—systematic review and methodological commentary

Review of clinical practice guidelines for the management of LDL-related risk

Residual macrovascular risk in 2013: what have we learned?

P304

1-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2017.64712

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Agnieszka Mastalerz-Migas

P577

2016-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28144253

http://www.w3.org/2001/XMLSchema#string

P921

P932

5206369

http://www.w3.org/2001/XMLSchema#string